|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels显示文摘 | IIRO R KATRI P | 2005 | Cancer Res2005，65，11： | 1 |
| 2 | Risk factors at pretreat- ment predicting treatment-induced nausea and vomiting in Australian cancer patients A prospective, longitudi- nal,observational study显示文摘 | Pirri C Katris P Trotter J | 2011 | Support Care Cancer2011，19，10： | 1 |
| 3 | Intravenous glycoprotein Ⅱb/Ⅲa receptor antagonists reduce mortality after percutaneous coronary interventions 显示文摘 | KARVOUNI E KATRI'FSIS D G I()ANN1D1S J P | 2003 | J Am Coil Cardiol2003，41，： | 1 |
| 4 | Largescale energy grass farming for power plants-A case study from Ostrobothnia,Finland显示文摘 | Katri P Mikko A Mika I | 2008 | Biomass and Bioenergy2008，32，： | 1 |
| 5 | Validity of Melanoma Diagnosis in a Community-based Screening Program 显示文摘 | Fritschi L Dye S A Katris P | 2006 | A Am J Epidemio12006，164，4： | 1 |
| 6 | A novel vas- cular endothelial growth factor, VEGF-C, is a lig- and for the Flt4 (VEGFR-3) and KDR (VEGFR- 2) receptor tyrosine kinases显示文摘 | VLADIMIR J KATRI P ARJA K | 1996 | The EMBO Journal1996，15，7： | 1 |
| 7 | Degree of Damage to the Small Bowel and Serum Antibody Titers Correlate With Clinical Presentation of Patients With Celiac Disease显示文摘 | Juha Taavela Kalle Kurppa Pekka Collin Marja–Leena L?hdeaho Teea Salmi P?ivi Saavalainen Katri Haimila Heini Huhtala Kaija Laurila Harri Siev?nen Markku M?ki Katri Kaukinen | 2013 | Clinical Gastroenterology and Hepatology2013，，： | 1 |
| 8 | Mapping the psy- chosocial and practical support needs of cancer patients in Western Australia 显示文摘 | White K D' Abrew N Katris P | 2012 | Eur J Cancer Care (Engl)2012，21，1： | 1 |
| 9 | Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels 显示文摘 | Yulong H Iiro R Katri P | 2005 | Cancer res2005，46，1： | 1 |
| 10 | Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation显示文摘AIM:To investigate the association between serum antibody levels and a subsequent celiac disease diag-nosis in a large series of children and adults. METHODS:Besides subjects with classical gastrointestinal presentation of celiac disease,the study cohort included a substantial number of individuals with extraintestinal symptoms and those found by screening in at-risk groups.Altogether 405 patients underwent clinical,serological and histological evaluations.After collection of data,the antibody values were further graded as low[endomysial(EmA)1:5-200,transglutaminase 2 antibodies(TG2-ab)5.0-30.0 U/L]and high (EmA 1:≥500,TG2-ab≥30.0 U/L),and the serological results were compared with the small intestinal mucosal histology and clinical presentation. RESULTS:In total,79%of the subjects with low and 94%of those with high serum EmA titers showed small-bowel mucosal villous atrophy.Furthermore, 96%of the 47 EmA positive subjects who had normal mucosal villi and remained on follow-up either subsequently developed mucosal atrophy while on a glutencontaining diet,or responded positively to a glutenfree diet. CONCLUSION:Irrespective of the initial serum titers or clinical presentation,EmA positivity as such is a very strong predictor of a subsequent celiac disease diagnosis. | Kalle Kurppa Tiia Rsnen Pekka Collin Sari Iltanen Heini Huhtala Merja Ashorn Pivi Saavalainen Katri Haimila Jukka Partanen Markku Mki Katri Kaukinen | 2012 | World Journal of Gastroenterology2012，18，20： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员